Wound and cutaneous injury healing with a nucleic acid encoding perlecan
A description of a biomolecule named Perlecan which is added internally or topically, or is expressed from exogenously added nucleic acids, as a whole or in part, to a healing wound to improve the success of wound healing is disclosed. Relevant embodiments for this patent technology are described.
1. A method for the effective healing of a wound or a cutaneous injury in a subject in need of such healing via delivery of a heparin sulfate-decorated perlecan molecule, the method comprising administering to the wound or cutaneous injury in the subject a nucleic acid coding for perlecan whereby said heparin sulfate-decorated perlecan molecule is generated by the subject, said nucleic acid being delivered in an amount sufficient to deliver an effective amount of heparin sulfate-decorated perlecan to the wound or cutaneous injury resulting in an in improvement in healing of the wound or cutaneous injury in the subject.
2. The method of claim 1 where the nucleic acid has the sequence of SEQ ID NO. 5.
3. The method of claim 1 where the nucleic acid codes for an amino acid having the sequence of SEQ ID NO. 4.
4. The method of claim 1 where the nucleic acid is a fragment of SEQ ID NO. 5.
5. The method of claim 4 where said fragment is at least 150 nucleotides in length and is selected from nucleotides 1-600 of SEQ ID NO. 5.
6. The method of claim 4 where said fragment codes for at least 50 amino acids selected from amino acids 1-172 of SEQ ID NO. 4.
7. The method of claim 4 where said fragment codes for amino acids 1-172 of SEQ ID NO. 4.
8. The method of claim 1 where said nucleic acid is delivered in a pharmaceutically acceptable carrier or diluent.
9. The method of claim 1 further comprising the administration of a modulating compound.
10. A method for the effective healing of a wound or a cutaneous injury in a subject in need of such healing via delivery of a heparin sulfate-decorated perlecan molecule, the method comprising administering to the wound or cutaneous injury in the subject a nucleic acid that is at least 70% identical to the nucleic sequence of SEQ ID NO. 5 whereby said heparin sulfate-decorated perlecan molecule is generated by the subject, said nucleic acid being delivered in an amount sufficient to deliver an effective amount of heparin sulfate-decorated perlecan to the wound or cutaneous injury resulting in an in improvement in healing of the wound or cutaneous injury in the subject.
11. The method of claim 10 where said nucleic acid is delivered in a pharmaceutically acceptable carrier or diluent.
12. The method of claim 10 further comprising the administration of a modulating compound.
13. A method for the effective healing of a wound or a cutaneous injury in a subject in need of such healing via delivery of a heparin sulfate-decorated perlecan molecule, the method comprising administering to the wound or cutaneous injury in the subject a nucleic acid that codes for a protein that is at least 70% identical to the amino acid sequence of SEQ ID NO. 4 whereby said heparin sulfate-decorated perlecan molecule is generated by the subject, said nucleic acid being delivered in an amount sufficient to deliver an effective amount of heparin sulfate-decorated perlecan to the wound or cutaneous injury resulting in an in improvement in healing of the wound or cutaneous injury in the subject.
14. The method of claim 13 where said nucleic acid is delivered in a pharmaceutically acceptable carrier or diluent.
15. The method of claim 13 further comprising the administration of a modulating compound.